[
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06931340\">Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06500481\">A Phase III Randomized Clinical Trial of Proton Craniospinal Irradiation Versus Involved-Field Radiotherapy for Patients with Breast Cancer or Non-Small Cell Lung Cancer Leptomeningeal Metastasis (Radiate-LM)</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05112601\">A Randomized Phase II Trial of Nivolumab and Ipilimumab Compared to Nivolumab Monotherapy in Patients with Deficient Mismatch Repair System Recurrent Endometrial Carcinoma</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06475989\">A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600Em</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05080673\">FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04068194\">A Phase I/ II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/ Metastatic Solid Tumors and Hepatobiliary Malignancies</a>",
        "Disease Type": "Gastrointestinal Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06223542\">A Phase I Study to Investigate the Safety of the Ubiquitin Activating Enzyme Inhibitor TAK-243 in Adult Solid Tumor and Lymphoma Patients</a>",
        "Disease Type": "Lymphoma; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06532279\">A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04423211\">Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06317662\">A Phase 2 Study of Blinatumomab in Combination with Chemotherapy for Infants with Newly Diagnosed Acute Lymphoblastic Leukemia with Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04462302\">Internet-delivered Management of Pain Among Cancer Treatment Survivors (IMPACTS)</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma); Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04671667\">A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab After Resection of Recurrent/ Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05432804\">A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04031677\">A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High Risk RetroPeritoneal Sarcoma (STRASS 2)</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06647953\">Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06368817\">A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05408845\">A Phase II Trial of HER2-Targeted Therapies for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05554393\">A Measurable Residual Disease (MRD) Focused, Phase II Study of Venetoclax Plus Chemotherapy for Newly Diagnosed Younger Patients with Intermediate Risk Acute Myeloid Leukemia: A Tier 1 MYELOMATCH SubStudy</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04301076\">A Phase 1 Study of Lenalidomide in Combination with EPOCH Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL)</a>",
        "Disease Type": "Leukemia; Lymphoma",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03488693\">Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06860594\">A Phase I Trial Combining Triapine with Radiation Therapy for Recurrent Glioblastoma or Astrocytoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05886036\">NORM: Nodular Lymphocyte-Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase 2 Trial with Either Rituximab or Mosunetuzumab</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06672146\">A Randomized Phase II Trial of ASTX727 and Venetoclax Compared with ASTX727, Venetoclax, and Enasidenib for Newly Diagnosed Older Adults with IDH2 Mutant Acute Myeloid Leukemia: A MyeloMATCH Substudy</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06769126\">PRISM: PRecIsion in SCLC Via a Multicohort Study: Randomized Phase II Studies Evaluating Maintenance Durvalumab with or Without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer (ES-SCLC)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03418961\">S1501, Prospective Observational Cohort Study of Patients with Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05111574\">A Randomized Phase II Trial of Adjuvant Nivolumab with or Without Cabozantinib in Patients with Resected Mucosal Melanoma</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04251052\">A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT02339571\">Randomized Phase II/ III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06235697\">Androgen Suppression Combined with Elective Nodal Irradiation and Dose Escalated Prostate Treatment: A Non-Inferiority, Phase III Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Brachytherapy Boost in Patients with Unfavorable Risk Localized Prostate Cancer (ASCENDE-SBRT)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06732401\">A Randomized Phase III Trial of Checkpoint Blockade in Lung CancEr Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03375307\">A Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/ Advanced Urothelial Carcinoma and Other Genitourinary Tumors with DNA-Repair Defects</a>",
        "Disease Type": "Endocrine Cancer; Germ Cell Cancer; Kidney Cancer; Male Reproductive System Cancer; Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05806515\">A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer with Germline BRCA1/ 2 Mutations</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06169215\">A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Diagnosed Multiple Myeloma</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05987241\">MODERN: An Integrated Phase 2/ 3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06418204\">Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics</a>",
        "Disease Type": "Breast Cancer; Gastrointestinal Cancer; Lung, Mediastinal, and Pleural Cancer; Lymphoma; Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05638295\">A Randomized Phase II Study of AMG 510 (Sotorasib) with or Without Panitumumab in Advanced Solid Tumors: A ComboMATCH Treatment Trial</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06513962\">Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05896189\">Cognitive Training For Cancer Related Cognitive Impairment In Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06279013\">Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment (SYMON)</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05564390\">MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI MyeloMATCH Clinical Trials</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04803201\">A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06654037\">A Phase 1 Study of 5-Fluorouracil in Combination with Abemaciclib in Metastatic, Refractory CRC</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07061977\">A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07018869\">A Pragmatic Randomized Controlled Trial To Evaluate The Effectiveness of an Intervention called Current Together After Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04242095\">Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05050084\">Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (GUIDANCE)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05372640\">A Phase 1 Study of BET Bromodomain Inhibitor ZEN003694 in Combination with the CDK4/ 6 Inhibitor Abemaciclib in Patients with NUT Carcinoma, Breast Cancer and Other Solid Tumors</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05646316\">A Phase III Trial Of The Impact Of Sentinel Lymph Node Mapping On Patient Reported Lower Extremity Limb Dysfunction In Endometrial Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06015880\">A Phase 1 Study of Mosunetuzumab with Polatuzumab Vedotin and Lenalidomide (M+Pola+Len) in Relapsed/ Refractory (R/ R) Diffuse Large B-Cell Lymphoma (DLBCL)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05353439\">Phase I Dose Escalation and Expansion Study of Tazemetostat in Combination with Topotecan and Pembrolizumab in Recurrent Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05934630\">CSF Cell-Free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06205485\">The NEO-RT Trial: A Phase 3 Randomized Trial of Neoadjuvant Chemotherapy, Excision and Observation Versus ChemoRadioTherapy for Early Rectal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06401330\">Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06671912\">LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04557956\">Phase 1/ 2 Study of an EZH2 Inhibitor (Tazemetostat) in Combination with Dual BRAF/ MEK Inhibition in Patients with BRAF- Mutated Metastatic Melanoma Who Progressed on Prior BRAF/ MEK Inhibitor Therapy</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06632977\">PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03678025\">Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04315324\">A Phase I/ II Study of AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) In Patients with Relapsed/ Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)/ T-Cell Lymphoblastic Lymphoma (T-LBL)</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05687110\">A Phase 1 Study of the Polymerase Theta (POL\u00bf) Inhibitor Novobiocin in BRCA- Mutant and Other DNA Damage Repair-Deficient Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04804644\">Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases from Small Cell Lung Cancer</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05642611\">Ice Compress: Randomized Trial of Limb Cryocompression Versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuropathy</a>",
        "Disease Type": "AIDS-related Malignancy and Condition; Bone Cancer; Breast Cancer; CNS Cancer (Primary tumor); Endocrine Cancer; Eye Cancer; Female Reproductive System Cancer; Gastrointestinal Cancer; Germ Cell Cancer; Head and Neck Cancer; Kidney Cancer; Lung, Mediastinal, and Pleural Cancer; Male Reproductive System Cancer; Miscellaneous and Metastatic Cancer; Skin Cancer; Soft Tissue Cancer/Sarcoma; Solid Tumor; Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03997370\">Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05561387\">A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of \"Intermediate Fit\" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07085728\">A Randomized Phase II Trial Comparing Daratumumab-Bortezomib-Dexamethasone Versus Cyclophosphamide-Bortezomib-Dexamethasone in Newly Diagnosed Multiple Myeloma with Light Chain Cast Nephropathy (LCCN)</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05886049\">A Phase 1b Study of Menin Inhibitor SNDX-5613 in Combination with Daunorubicin and Cytarabine in Newly Diagnosed Patients with Acute Myeloid Leukemia and NPM1 Mutated/ FLT3 Wildtype with Higher-Risk Features or MLL/ KMT2A Rearranged Disease or NUP98 Alterations Disease</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04134260\">Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying treatment for NOde positive prostate cancer by VArying the hormonal ThErapy</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05859334\">A Phase 2 Study of Erdafitinib in Patients with Recurrent or Progressive IDH-Wild Type Glioma with an FGFR-TACC Gene Fusion</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05111561\">A Phase 1 Study of ZEN003694 in Combination with Binimetinib in Solid Tumors with RAS Pathway Alterations and Triple Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06500455\">Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04840589\">Phase I/ Ib Trial Evaluating the Safety and Efficacy of BET Inhibitor, ZEN003694 with PD-1 Inhibitor, Nivolumab with or Without CTLA-4 Inhibitor, Ipilimumab in Solid Tumors</a>",
        "Disease Type": "Female Reproductive System Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04684368\">A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04939090\">A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06232044\">A Phase I/ II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination with Iberdomide (CC-220)/ Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/ Dexamethasone in Relapsed Refractory Multiple Myeloma</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT02474160\">Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma); Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06112613\">Improving Medication Adherence in Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05019716\">A Phase 1/ 2 Study of the Bromodomain Inhibitor ZEN003694 in Combination with Etoposide/ Platinum in Patients with NUT Carcinoma</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06470243\">A Phase III Study of Cabazitaxel with or Without Carboplatin in Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC), Stratified by Aggressive Variant Signature</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07091617\">AYA Access Study: An Enhanced eHealth and Chat-Bot Enabled Delivery Model for Clinical Genetic Services in Community AYA Cancer Patients</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer; Non-neoplastic Disorder",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION, OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06022939\">A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis</a>",
        "Disease Type": "Immune Disorder (excluding AIDS and malignancy)",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05627245\">Phase 1/ Expansion Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06649812\">A Phase 2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed or Refractory CD10-Negative Diffuse-Large B-Cell Lymphoma (DLBCL) and High-Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements (HGBCL-DH-BCL2)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05976763\">A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06029270\">A Randomized Phase II Study of Nivolumab Versus Nivolumab and BMS-986016 (Relatlimab) as Maintenance Treatment After First-Line Treatment with Platinum-Gemcitabine-Nivolumab for Patients with Epstein-Barr Virus-Associated Recurrent/ Metastatic Nasopharyngeal Carcinoma (REMAIN)</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04314401\">Cancer Moonshot Biobank Research Protocol</a>",
        "Disease Type": "Breast Cancer; Female Reproductive System Cancer; Gastrointestinal Cancer; Leukemia; Lung, Mediastinal, and Pleural Cancer; Male Reproductive System Cancer; Myeloma; Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": null,
        "Disease Type": "Bone Cancer; Breast Cancer; CNS Cancer (Primary tumor); Endocrine Cancer; Female Reproductive System Cancer; Gastrointestinal Cancer; Germ Cell Cancer; Leukemia; Lymphoma; Miscellaneous and Metastatic Cancer; Skin Cancer; Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "Pilot",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04579224\">A Phase III Randomized Trial of Eribulin (NSC #707389) with Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/ PDL1 Therapy</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05372614\">Phase I Trial of DS-8201a (Trastuzumab Deruxtecan) in Combination with Neratinib in Solid Tumors with HER2 Alterations</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06616584\">A Randomized Phase II/ III Study of Docetaxel and Ramucirumab with or Without Cemiplimab (REGN2810) for Participants Previously Treated with Platinum-Based Chemotherapy and Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05136196\">Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants with Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study</a>",
        "Disease Type": "Head and Neck Cancer; Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04799275\">A Phase II/ III Randomized Study of R-MiniCHOP with or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older with Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas with MYC AND BCL2 and/ or BCL6 Rearrangements</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05411081\">A Phase II Randomized Trial of Cabozantinib (NSC #761968) with or Without Atezolizumab (NSC #783608) in Patients with Advanced Papillary Renal Cell Carcinoma (PAPMET2)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06514261\">Phase 1 Trial of Iadademstat in Combination with Venetoclax and Azacitidine in Patients with Treatment Naive AML</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05946213\">The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05050162\">Randomized Phase II/ III Trial of Radiation with Cisplatin at 100 mg/ m2 Every Three Weeks Versus Radiation with Weekly Cisplatin at 40 mg/ m2 for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05711615\">A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil\u00ae) in Patients with Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas</a>",
        "Disease Type": "Female Reproductive System Cancer; Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04566328\">Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06179888\">Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04546399\">A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination with Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/ = 1 to < 31 Years Old with First Relapse</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05554328\">A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients with Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05685602\">A Phase I Clinical Trial of CA-4948 in Combination with Gemcitabine and Nab-Paclitaxel in Metastatic or Unresectable Pancreatic Ductal Carcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06102902\">A Phase 1 Study of ZEN003694 (ZEN-3694) in Combination with Cetuximab and Encorafenib in Patients with Refractory BRAF V600E Metastatic Colorectal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04847453\">A Phase 1/ 1a Study of Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for Relapsed/ Refractory Light Chain Amyloidosis</a>",
        "Disease Type": "Immune Disorder (excluding AIDS and malignancy)",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03866382\">A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)</a>",
        "Disease Type": "Germ Cell Cancer; Kidney Cancer; Male Reproductive System Cancer; Miscellaneous and Metastatic Cancer; Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04963153\">Phase Ib Trial of Erdafitinib Combined with Enfortumab Vedotin Following Platinum and PD1/ L1 Inhibitors for Metastatic Urothelial Carcinoma with FGFR2/ 3 Genetic Alterations</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03067181\">A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors</a>",
        "Disease Type": "Germ Cell Cancer; Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06031688\">A Randomized Phase II Study of Tepotinib with or Without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03191149\">Phase II Study of Osimertinib (AZD9291) in Advanced NSCLC Patients with Exon 20 Insertion Mutations in EGFR</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06311214\">Optimizing Antibody-Drug Conjugate Therapy Through Molecular Analysis for Therapy Choice (ADC MATCH)</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03180268\">Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04494113\">A Phase 0 Window-of-Opportunity Pharmacodynamic Trial of Triapine (NSC# 663249) in Uterine Corpus Serous Adenocarcinoma</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "0",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06802523\">A Phase I Study of Lintuzumab-Ac-225 in Combination with Venetoclax and ASTX-727 in Adults with Newly Diagnosed AML</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05289687\">A Phase II Study of Daratumumab-Hyaluronidase for Chemotherapy-Relapsed/ Refractory Minimal Residual Disease (MRD) in T Cell Acute Lymphoblastic Leukemia/ Lymphoma (T-ALL/ T-LBL)</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04550494\">A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients with Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response</a>",
        "Disease Type": "Breast Cancer; Female Reproductive System Cancer; Gastrointestinal Cancer; Male Reproductive System Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03998202\">Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05673148\">A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06319027\">Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03723928\">Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) versus Usual Care in Patients with Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06592924\">A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05364086\">Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/ anti-PD-L1 Immunotherapy in a Community Oncology Setting</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma); Miscellaneous and Metastatic Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05673200\">Phase I Study Targeting DNA Methyltransferases in Metastatic Triple-Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04852887\">A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05554406\">A Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7 + 3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients Aged 59 or Younger Who are Considered High-Risk (Adverse) Acute Myeloid Leukemia As Determined by MYELOMATCH; A MYELOMATCH Clinical Trial</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06724237\">A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T Cell Lymphoma That Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05647265\">Multimodality Therapy with Immunotherapy in Stage I-IIIA Pleural Mesothelioma</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05691504\">A Phase 1 Study of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06589804\">Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/ Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04181060\">Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05691465\">A Phase II Study of Lutetium Lu 177 Dotatate in Metastatic Prostate Cancer with Neuroendocrine Differentiation</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03994796\">Genomically-Guided Treatment Trial in Brain Metastases</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05327010\">Phase 2 Trial of the Combination of the BET Inhibitor, ZEN003694 (ZEN-3694), and the PARP Inhibitor Talazoparib, in Patients with Molecularly-Selected Solid Tumors (ComBET)</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04402788\">RAndomized Phase II/ III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05438212\">A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients with Resectable Brain Metastases</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06172296\">A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma</a>",
        "Disease Type": "Nervous System Cancer (CNS-excluded)",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05691491\">A Phase 1/ 2 Trial Evaluating the Combination of Temozolomide and the Ataxia Telangiectasia and Rad3-Related Inhibitor M1774</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05451004\">SPECT-CT Guided Elective Contralateral Neck Treatment [SELECT] for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04071236\">A Phase I and  Randomized Phase II Trial of Radium-223 Dichloride, M3814, & Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04840602\">A Phase II Randomized Study Comparing Ibrutinib and Rituximab vs. Venetoclax and Rituximab in Previously Untreated Waldenstr\u00f6m's Macroglobulinemia (WM) /  Lymphoplasmacytic Lymphoma (LPL)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06606990\">Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05677490\">Randomized Phase III Trial of mFOLFIRINOX +/ - Nivolumab vs. FOLFOX +/ - Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06203600\">Randomized Phase II/ III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS >/ = 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04310020\">A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06577441\">A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2-Mutated Myelodysplastic Syndrome: A MyeloMATCH Sub-Study</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06661915\">A Randomized Phase 2 Trial of ASTX727 +/ - Iadademstat in Accelerated/ Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05198830\">A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination with Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05040360\">Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04665739\">Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07097142\">The Phase III Adaptive Radiation and Chemotherapy for Muscle Invasive Bladder Cancer Trial (ARCHER)</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06096844\">A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT02402244\">The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04981509\">A Phase 2 Study of Bevacizumab, Erlotinib and Atezolizumab in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Associated or Sporadic Papillary Renal Cell Cancer</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05379153\">The Revitalize Trial: Reducing Vaginal Atrophy with Fractional CO2 Laser for Breast Cancer Survivors</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05272384\">A Phase 1 Study of Nivolumab in Combination with ASTX727 in B-cell Lymphoma (NHL or HL) with an Expansion Cohort in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin lymphoma (HL)</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06756607\">The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "0",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06894979\">A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AZD1390 (NSC# 852149, IND# 172675) When Combined with Focal Radiation in Pediatric Patients with High Grade Glioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06498648\">Phase I/ II Study to Evaluate the Feasibility and Efficacy of Sequential Abemaciclib and Gemcitabine Treatment in Patients with Retinoblastoma (Rb)+ Sarcomas</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "1/2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06498635\">A Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants with Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in the AdjuvanT Setting (INSIGHT)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06465316\">A Phase 1b Trial of Teclistamab in Combination with Iberdomide for Relapsed/ Refractory Multiple Myeloma</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03811015\">A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPSCC</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04269902\">Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/ SLL): EVOLVE CLL/ SLL Study</a>",
        "Disease Type": "Leukemia; Lymphoma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05008848\">Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05256225\">A Phase II/ III Study of Paclitaxel/ Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05600894\">Venetoclax In Combination with ASTX727, an All-ORal TherapY for Chronic Myelomonocytic Leukemia and Other MDS/ MPN with Excess Blasts (VICTORY-MDS/ MPN): a Randomized, Phase 2 Trial</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04071223\">A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis (RadiCal)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05724108\">A Phase II Randomized Control Trial of Triapine Plus Lutetium Lu 177 Dotatate Versus Lutetium Lu 177 Dotatate Alone for Well-Differentiated Somatostatin Receptor-Positive Neuroendocrine Tumors</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05691478\">A Feasibility and Randomized Phase 2/ 3 Study of the VEGFR2/ MET Inhibitor Cabozantinib in Combination with Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma</a>",
        "Disease Type": "Bone Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04628767\">A Phase II/ III Trial of Durvalumab and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06888323\">Phase 1 Study of Lintuzumab-Ac225 Monotherapy for Patients with Hypomethylating Agent-Refractory Myelodysplastic Syndrome</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04585958\">A Phase I Study of DS-8201a in Combination with Olaparib in HER2-Expressing Malignancies</a>",
        "Disease Type": "Female Reproductive System Cancer; Solid Tumor",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05053152\">A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy with or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06002828\">Social Genomic Mechanisms of Health Disparities among Adolescent and Young Adult (AYA) Cancer Survivors</a>",
        "Disease Type": "Leukemia; Lymphoma",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06325683\">Randomized Phase II Trial of Anti-Lag-3 and Anti-PD-1 Blockade vs. SOC in Patients with Recurrent Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06050252\">A Phase II Trial of Durvalumab with Gemcitabine and Cisplatin as Neoadjuvant Therapy for High-Risk Resectable Intrahepatic Cholangiocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT02734537\">Phase II Randomized Trial of Radiotherapy with or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05703269\">Hypofractionated Radiotherapy vs Single Fraction Radiosurgery for Brain Metastasis Patients on Immunotherapy (HYPOGRYPHE)</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03550391\">A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) plus Memantine for 5-15 Brain Metastases</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06058377\">Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone for Adults with MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive /  Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05896839\">A Phase 2 Study of Nivolumab and Ipilimumab in Combination with Sirolimus and Prednisone in Kidney Transplant Recipients with Selected Unresectable or Metastatic Cutaneous Cancers</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04510597\">Phase III Trial of Immunotherapy-Based Combination Therapy with or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05564377\">Molecular Analysis for Combination Therapy Choice (ComboMATCH)</a>",
        "Disease Type": "Lymphoma; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05001880\">Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or Without Immunotherapy for Peritoneal Mesothelioma</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06317649\">A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Treatment Trial</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05773274\">NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus or Sunitinib or Cabozantinib in Metastatic/ Unresectable Gastroenteropancreatic Neuroendocrine Tumours</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05642572\">A Randomized Phase II Study of Capmatinib Plus Osimertinib with or Without Ramucirumab in Participants with EGFR-Mutant, MET-Amplified Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": null,
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma); Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05761171\">A Phase 2 Study of SNDX-5613 in Combination with Chemotherapy for Patients with Relapsed or Refractory KMT2A-Rearranged Infant Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06876714\">ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients with Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy with HER2 Blockade</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04929041\">A Randomized Phase II/ III Trial of Modern Immunotherapy Based Systemic Therapy with or Without Radiation Therapy for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06295367\">Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03609216\">A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07000084\">GAIN-BCG: Gemcitabine Alternating with INtravesical BCG Randomized Against BCG Alone for Patients with Recurrent High Grade Non-Muscle Invasive Bladder Cancer</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05053971\">Phase Ib/ II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors</a>",
        "Disease Type": "Gastrointestinal Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05879926\">A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/ HER2-Negative Breast Cancer and an Oncotype Recurrence Score </= 25 (OFSET)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05411094\">A Phase 1 Study of Olaparib in Combination with Durvalumab (MEDI4736) and Concurrent Radiation Therapy Following First-Line Chemotherapy in Locally Advanced Unresectable Pancreatic Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04172532\">A Phase 1/ 2 Study of M3814 (Peposertib) in Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05812807\">OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05602194\">A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy</a>",
        "Disease Type": "Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03801876\">Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03186898\">A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": null,
        "Disease Type": "N/A",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05863195\">A Randomized Phase III Study of Systemic Therapy with or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03739814\">A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05803382\">Phase I Trial of ZEN003694 (ZEN-3694) in Combination with Capecitabine in Patients with Solid Tumors</a>",
        "Disease Type": "Gastrointestinal Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06439836\">Phase 1 Trial of CA-4948 in Combination with Pembrolizumab to Overcome Resistance to PD-1/ PD-L1 Blockade in Metastatic Urothelial Cancer</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05058651\">Randomized Phase II/ III Trial of First Line Platinum/ Etoposide with or Without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06124157\">An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04870944\">A Phase 1/ 2 Trial of CBL0137 (NSC# 825802) in Patients with Relapsed or Refractory Solid Tumors Including CNS Tumors and Lymphoma</a>",
        "Disease Type": "Bone Cancer; CNS Cancer (Primary tumor); Lymphoma; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04633239\">A Phase 1/ 1b Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum-Resistant Ovarian Cancer</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT02523014\">Phase II Trial of SMO/  AKT/  NF2/ CDK Inhibitors in Progressive Meningiomas with SMO/  AKT/  NF2/ CDK Pathway Mutations</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04333537\">Randomized Phase II/ III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2/3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04871542\">Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study</a>",
        "Disease Type": "N/A",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "OTHER"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05077527\">Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphoma</a>",
        "Disease Type": "AIDS-related Malignancy and Condition",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04704661\">Phase 1/ 1B Study of DS-8201a in Combination with ATR Inhibition (AZD6738) in Advanced Solid Tumors with HER2 Expression (DASH Trial)</a>",
        "Disease Type": "Gastrointestinal Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06661720\">Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06686771\">Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients with Metastatic Non-Small-Cell Lung Cancer - A Randomized Phase 3 Trial</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04539366\">GD2-CAR PERSIST: Production and Engineering of GD2-Targeted, Receptor Modified T Cells (GD2CART) for Osteosarcoma or Neuroblastoma to Increase Systemic Tumor Exposure</a>",
        "Disease Type": "Bone Cancer; Nervous System Cancer (CNS-excluded)",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04482933\">Phase 2 Trial of G207 + 5 Gy Radiation for Children with High-Grade Gliomas</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06807437\">A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula</a>",
        "Disease Type": "Endocrine Cancer; Gastrointestinal Cancer; Miscellaneous and Metastatic Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04239573\">Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06126276\">A Randomized Trial of Neratinib, A Pan-ERBB Inhibitor, Alone or in Combination with Palbociclib, a CDK4/ 6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors: A ComboMATCH Treatment Trial</a>",
        "Disease Type": "Bone Cancer; CNS Cancer (Primary tumor); Endocrine Cancer; Female Reproductive System Cancer; Gastrointestinal Cancer; Germ Cell Cancer; Head and Neck Cancer; Kidney Cancer; Lung, Mediastinal, and Pleural Cancer; Male Reproductive System Cancer; Miscellaneous and Metastatic Cancer; Skin Cancer; Soft Tissue Cancer/Sarcoma; Solid Tumor; Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06696768\">Phase I Clinical Trial of CA-4948 (Emavusertib) in Combination with FOLFOX Plus Bevacizumab as Frontline Treatment in Patients with Metastatic Colorectal Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05675410\">A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04858334\">APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05172245\">Phase 1/ 1b Study of AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05828069\">Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis</a>",
        "Disease Type": "Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma)",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06632327\">Perioperative Versus Adjuvant Systemic Therapy in Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05687136\">A Molecularly Driven Phase 1b Dose Escalation and Dose Expansion Study of the DNA-PK Inhibitor Peposertib (M3814) in Combination with the ATR Inhibitor M1774</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03150693\">A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06965114\">A Phase 1 Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab with Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03907475\">DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination with Chemotherapy in Patients with Advanced Solid Tumors</a>",
        "Disease Type": "Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05095376\">A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06064097\">A Phase 2 Study Using Chemoimmunotherapy with Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06388018\">A Phase II Study of Tailored Adjuvant Therapy in Pole-Mutated and p53-Wildtype/ NSMP Early-Stage Endometrial Cancer (RAINBO BLUE & TAPER)</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03816319\">A Phase 1 Study of TAK-243 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes with Increased Blasts</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05669664\">A Phase 2 Study of Darolutamide in Combination with Leuprolide Acetate in Hormone-Therapy Naive Recurrent and/ or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05333458\">A Phase 2 Study of Atezolizumab with Selinexor in Alveolar Soft Part Sarcoma (AXIOM)</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT02305654\">InPACT- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)</a>",
        "Disease Type": "Male Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06116682\">A Phase II Study of Amivantamab Hyaluronidase in Participants with MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04978727\">A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients with Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma</a>",
        "Disease Type": "CNS Cancer (Primary tumor)",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06811116\">A Phase I/ II Trial of Sapanisertib in Combination with Cabozantinib in \u00df-catenin-mutated Hepatocellular Carcinoma (SAPHIRE)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06311227\">A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05327686\">Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)</a>",
        "Disease Type": "Kidney Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03816345\">A Phase Ib Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)</a>",
        "Disease Type": "Female Reproductive System Cancer; Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma); Kidney Cancer; Lung, Mediastinal, and Pleural Cancer; Lymphoma; Skin Cancer; Solid Tumor; Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03604991\">A Phase II/ III Study of Peri-Operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04205968\">Randomized Phase II Selection Study of Ramucirumab and Paclitaxel Versus FOLFIRI in Refractory Small Bowel Adenocarcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT02582697\">A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors</a>",
        "Disease Type": "Germ Cell Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04530565\">A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) in Adults</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06620302\">DT2216 (NSC#850950, IND# 170973) in Combination with Irinotecan for Children, Adolescents and Young Adults with Relapsed or Refractory Solid Tumors: A Phase I Study with Phase II Feasibility Cohort for Fibrolamellar Carcinoma</a>",
        "Disease Type": "Gastrointestinal Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06115499\">Phase II/ III Second-Line NABPLAGEM vs. Nab-Paclitaxel/ Gemcitabine in BRCA1/ 2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM)</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07061964\">Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)</a>",
        "Disease Type": "Urothelial/ Bladder Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06568172\">Randomized Phase III Trial of Neoadjuvant Immunotherapy with Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/ IV Cutaneous Squamous Cell Carcinoma</a>",
        "Disease Type": "Skin Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04340141\">A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04155034\">MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06287775\">A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined with Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "1/2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT01810913\">Randomized Phase II/ III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06337318\">Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05422794\">A Phase 1b Trial of ZEN003694 (ZEN-3694) with Pembrolizumab and Nab-Paclitaxel in Patients with Metastatic Triple-Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03851445\">A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06364410\">Phase 1 Study of Trastuzumab Deruxtecan (DS-8201a) in Combination with Azenosertib (ZN-c3) in HER2-Expressing/ Amplified Cyclin E-Amplified Gastric/ Gastroesophageal Junction Cancer and Other Solid Tumors with HER2 Expression</a>",
        "Disease Type": "Gastrointestinal Cancer; Solid Tumor",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05904080\">Randomized Phase 2 Study of Nivolumab and Ipilimumab with or Without Cabozantinib in Patients with Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05721755\">Phase III Randomized Trial of Immunotherapy with or Without Consolidative Radiotherapy for Oligometastatic Head and Neck Squamous Cell Carcinoma</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06484062\">A Phase I Study Evaluating the Safety of Cirtuvivint as Monotherapy and in Combination with ASTX727 in Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05890352\">Randomized Phase II Study of the Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Non-Transplant-Eligible Patients with Relapsed/ Refractory Large B-Cell Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05633615\">A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment For Relapsed/ Refractory Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma</a>",
        "Disease Type": "Lymphoma",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05687123\">A Phase I Dose Escalation-Expansion Trial of Sunitinib Malate Plus Lutetium Lu 177 Dotatate (Lutathera) in Somatostatin Receptor Positive Pancreatic Neuroendocrine Tumors</a>",
        "Disease Type": "Endocrine Cancer",
        "Protocol Status": "Active",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05235165\">A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma</a>",
        "Disease Type": "Bone Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03983824\">A Phase I Study of M3814 in Combination with MEC in Patients with Relapsed or Refractory Acute Myeloid Leukemia</a>",
        "Disease Type": "Leukemia",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "1",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06580314\">A Phase III Trial of One vs. Two Years of Maintenance Olaparib, with or Without Bevacizumab, in Patients with BRCA1/ 2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy</a>",
        "Disease Type": "Female Reproductive System Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06422806\">A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Dedifferentiated Liposarcoma (DDLPS), Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas</a>",
        "Disease Type": "Soft Tissue Cancer/Sarcoma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04267848\">Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)</a>",
        "Disease Type": "Lung, Mediastinal, and Pleural Cancer",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03606967\">Randomized Phase 2 Clinical Trial of Nab-Paclitaxel + Durvalumab (MEDI4736) + Tremelimumab + Neoantigen Vaccine Vs. Nab-Paclitaxel + Durvalumab (MEDI4736) + Tremelimumab in Patients with Metastatic Triple Negative Breast Cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT04548752\">Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "2",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT07001748\">A Randomized Phase II/ III Trial of Intraperitoneal Paclitaxel Plus Systemic Treatment vs Systemic Treatment Alone in Gastric Carcinomatosis - STOPGAP II</a>",
        "Disease Type": "Gastrointestinal Cancer",
        "Protocol Status": "Active",
        "Phase": "2/3",
        "Trial Type": "SCREENING, INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT03937635\">Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)</a>",
        "Disease Type": "Myeloma",
        "Protocol Status": "Active",
        "Phase": "3",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.adventisthealth.org/bakersfield/services/cancer-center/\">Aromatherapy in patients receiving chemotherapy in the outpatient setting</a>",
        "Disease Type": "All Cancer Types",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://moonshotbiobank.cancer.gov/\">Cancer Moonshot Biobank</a>",
        "Disease Type": "All Cancer Types",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "BIOBANK"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06770582\">Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial)</a>",
        "Disease Type": "Bladder Cancer",
        "Protocol Status": "Active*",
        "Phase": "II",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.thewisdomstudy.org/\">Women Informed to Screen Depending on Measures of Risk (Wisdom Study)</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT06058377\">A Randomized trial of neoadjuvant durvalumab plus chemotherapy versus chemotherapy alone for Adults with MammaPrint Ultrahigh (MP2) hormone receptor (HR) positive /Human Epidermal Growth Factor receptor (HER2) negative stage II-III breast cancer</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/study/NCT05896189\">Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Temporarily Closed to Accrual",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT05929768\">Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/study/NCT06748222\">Harnessing E-Mindfulness Approaches for Living After Breast Cancer --- HEAL-ABC</a>",
        "Disease Type": "Breast Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://joincountmein.org/colorectal\">Colorectal Cancer Project</a>",
        "Disease Type": "Colorectal Cancer",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05174169\">Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-NORTH AMERICA)</a>",
        "Disease Type": "Colorectal Cancer",
        "Protocol Status": "Active*",
        "Phase": "II/III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.clinicaltrials.gov/study/NCT06992427\">High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial</a>",
        "Disease Type": "Head and Neck Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://www.joinallofus.org/\">All of Us Research Program</a>",
        "Disease Type": "Healthy Volunteers",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://inheritedcancer.net/\">Inherited Cancer Registry - Hereditary Cancers Inherited Cancer - Genetics</a>",
        "Disease Type": "Inherited Cancer - Genetics",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05334069\">Blinded Reference Set For Multicancer Early Detection Blood Tests</a>",
        "Disease Type": "Multiple",
        "Protocol Status": "Active*",
        "Phase": "Other",
        "Trial Type": "BIOBANK"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/study/NCT06745024\">Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)</a>",
        "Disease Type": "Multiple",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05624996\">Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer</a>",
        "Disease Type": "Non-small Cell Lung Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/study/NCT06958328\">A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)</a>",
        "Disease Type": "Pancreatic Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://braintumorproject.org/\">Brain Tumor Project</a>",
        "Disease Type": "Primary Brain Tumor",
        "Protocol Status": "Closed to Accrual",
        "Phase": "Other",
        "Trial Type": "SCREENING"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT05050084\">Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)</a>",
        "Disease Type": "Prostate Cancer",
        "Protocol Status": "Active*",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    },
    {
        "Title": "<a target=\"_blank\" href=\"https://clinicaltrials.gov/ct2/show/NCT04513717\">Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)</a>",
        "Disease Type": "Prostate Cancer",
        "Protocol Status": "Closed to Accrual",
        "Phase": "III",
        "Trial Type": "INTERVENTION"
    }
]
